Mabvax Therapeutics Holdings Inc Share Price Other OTC
Equities
US55414P7024
Biotechnology & Medical Research
Sales 2016 | 148K 12.35M | Sales 2017 | - | Capitalization | 14.41M 1.2B |
---|---|---|---|---|---|
Net income 2016 | -17M -1.42B | Net income 2017 | -19M -1.58B | EV / Sales 2016 | 147 x |
Net Debt 2016 | 470K 39.22M | Net Debt 2017 | 2.48M 207M | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.93
x | P/E ratio 2017 |
-0.25
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 92.02% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 72 | - | |
Chief Tech/Sci/R&D Officer | 81 | 08/14/08 | |
Paul W. Maffuid
CTO | Chief Tech/Sci/R&D Officer | 68 | 08/14/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 81 | 08/14/08 |
1st Jan change | Capi. | |
---|---|---|
+16.45% | 123B | |
+21.96% | 115B | |
+23.73% | 25.85B | |
-20.05% | 20.9B | |
-16.28% | 16.77B | |
-16.52% | 16.52B | |
-44.35% | 15.56B | |
+63.91% | 15.49B | |
+2.52% | 13.45B |